Athira Pharma Inc (ATHA)
2.71
+0.50
(+22.62%)
USD |
NASDAQ |
May 16, 16:00
2.62
-0.09
(-3.32%)
After-Hours: 04:16
Athira Pharma Shareholders Equity (Quarterly): 130.19M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 130.19M |
| September 30, 2023 | 154.76M |
| June 30, 2023 | 184.98M |
| March 31, 2023 | 211.12M |
| December 31, 2022 | 235.14M |
| September 30, 2022 | 262.25M |
| June 30, 2022 | 280.56M |
| March 31, 2022 | 301.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 321.08M |
| September 30, 2021 | 336.24M |
| June 30, 2021 | 350.71M |
| March 31, 2021 | 363.22M |
| December 31, 2020 | 274.28M |
| September 30, 2020 | 259.47M |
| June 30, 2020 | 79.92M |
| December 31, 2019 | -19.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-19.72M
Minimum
Dec 2019
363.22M
Maximum
Mar 2021
232.89M
Average
260.86M
Median
Shareholders Equity (Quarterly) Benchmarks
| Xeris Biopharma Holdings Inc | -9.178M |
| Kodiak Sciences Inc | 265.78M |
| Phathom Pharmaceuticals Inc | -148.50M |
| Arcutis Biotherapeutics Inc | 224.94M |
| Inozyme Pharma Inc | 118.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.24M |
| Total Liabilities (Quarterly) | 30.06M |